Protagonist Therapeutics Inc buy Barclays PLC
Start price
26.02.26
/
50%
€77.00
Target price
26.02.27
€95.61
Performance (%)
1.30%
Price
27.02.26
€78.00
Summary
This prediction is currently active. With a performance of 1.30%, the BUY prediction by Barclays_PLC for Protagonist Therapeutics Inc is trending in the right direction. This prediction currently runs until 26.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Protagonist Therapeutics Inc | 1.30% |
| iShares Core DAX® | -0.383% |
| iShares Nasdaq 100 | -0.411% |
| iShares Nikkei 225® | 1.838% |
| iShares S&P 500 | -0.712% |
Comments by Barclays_PLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Barclays PLC from $108.00 to $113.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Barclays_PLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
07.11.25
07.11.25
€76.27
07.11.26
07.11.26
13.04%
27.02.26
27.02.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€53.00
17.09.25
17.09.25
€60.73
17.09.26
17.09.26
47.17%
27.02.26
27.02.26